A re‐assessment of the role of combined androgen blockade for advanced prostate cancer

This publication has 16 references indexed in Scilit:

• Design and analysis of non‐inferiority mortality trials in oncology
  Statistics in Medicine, 2002
• An evaluation of bicalutamide in the treatment of prostate cancer
  Expert Opinion on Pharmacotherapy, 2002
• Systematic review and meta‐analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma
  Cancer, 2002
• Active-control trials: How would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo
  American Heart Journal, 2001
• Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials
  The Lancet, 2000
• Analysis of exon 1 mutations in the androgen receptor gene
  Human Mutation, 1999
• Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system
  British Journal of Cancer, 1999
• Receptor affinity and potency of non-steroidal antiandrogens: translation of preclinical findings into clinical activity
  Prostate Cancer and Prostatic Diseases, 1998
• Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer
  New England Journal of Medicine, 1998
• Ligand-induced Conformational Alterations of the Androgen Receptor Analyzed by Limited Trypsinization
  Journal of Biological Chemistry, 1995